These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 12859993
1. Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway. Lavelle D, DeSimone J, Hankewych M, Kousnetzova T, Chen YH. Leuk Res; 2003 Nov; 27(11):999-1007. PubMed ID: 12859993 [Abstract] [Full Text] [Related]
2. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells. Shin DY, Sung Kang H, Kim GY, Kim WJ, Yoo YH, Choi YH. Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784 [Abstract] [Full Text] [Related]
3. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Lepley DM, Pelling JC. Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954 [Abstract] [Full Text] [Related]
4. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells. Schmidt M, Fan Z. Oncogene; 2001 Sep 27; 20(43):6164-71. PubMed ID: 11593424 [Abstract] [Full Text] [Related]
5. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma. Shang D, Han T, Xu X, Liu Y. Int J Clin Exp Pathol; 2015 Sep 27; 8(9):11140-8. PubMed ID: 26617834 [Abstract] [Full Text] [Related]
6. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism. Kuwahara Y, Charboneau A, Knudsen ES, Weissman BE. Cancer Res; 2010 Mar 01; 70(5):1854-65. PubMed ID: 20179200 [Abstract] [Full Text] [Related]
7. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression. Rorke EA, Zhang D, Choo CK, Eckert RL, Jacobberger JW. Exp Cell Res; 2000 Aug 25; 259(1):149-57. PubMed ID: 10942587 [Abstract] [Full Text] [Related]
8. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D. Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250 [Abstract] [Full Text] [Related]
9. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest. Vijayaraghavalu S, Dermawan JK, Cheriyath V, Labhasetwar V. Mol Pharm; 2013 Jan 07; 10(1):337-52. PubMed ID: 23215027 [Abstract] [Full Text] [Related]
10. Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status. Xiong J, Epstein RJ. Mol Cancer Ther; 2009 Apr 07; 8(4):779-85. PubMed ID: 19372550 [Abstract] [Full Text] [Related]
11. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint. Garner AP, Weston CR, Todd DE, Balmanno K, Cook SJ. Oncogene; 2002 Nov 21; 21(53):8089-104. PubMed ID: 12444545 [Abstract] [Full Text] [Related]
12. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines. Patel AC, Anna CH, Foley JF, Stockton PS, Tyson FL, Barrett JC, Devereux TR. Carcinogenesis; 2000 Sep 21; 21(9):1691-700. PubMed ID: 10964101 [Abstract] [Full Text] [Related]
13. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, Kim BK, Lee YY. Cancer Res; 2000 Jun 01; 60(11):3065-71. PubMed ID: 10850458 [Abstract] [Full Text] [Related]
14. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. Park WH, Kim ES, Kim BK, Lee YY. Int J Oncol; 2003 Jul 01; 23(1):197-204. PubMed ID: 12792794 [Abstract] [Full Text] [Related]
15. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK. Gynecol Oncol; 2001 Dec 01; 83(3):543-8. PubMed ID: 11733969 [Abstract] [Full Text] [Related]
16. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin. McVean M, Weinberg WC, Pelling JC. Mol Carcinog; 2002 Jan 01; 33(1):36-43. PubMed ID: 11807956 [Abstract] [Full Text] [Related]
17. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line. Yamasaki F, Hama S, Yoshioka H, Kajiwara Y, Yahara K, Sugiyama K, Heike Y, Arita K, Kurisu K. Cancer Chemother Pharmacol; 2003 Apr 01; 51(4):271-83. PubMed ID: 12721754 [Abstract] [Full Text] [Related]
18. Obatoclax induces G1/G0-phase arrest via p38/p21(waf1/Cip1) signaling pathway in human esophageal cancer cells. Zhong D, Gu C, Shi L, Xun T, Li X, Liu S, Yu L. J Cell Biochem; 2014 Sep 01; 115(9):1624-35. PubMed ID: 24788582 [Abstract] [Full Text] [Related]
19. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells. Yamato K, Koseki T, Ohguchi M, Kizaki M, Ikeda Y, Nishihara T. Mol Endocrinol; 1997 Jul 01; 11(8):1044-52. PubMed ID: 9212052 [Abstract] [Full Text] [Related]
20. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Bender CM, Pao MM, Jones PA. Cancer Res; 1998 Jan 01; 58(1):95-101. PubMed ID: 9426064 [Abstract] [Full Text] [Related] Page: [Next] [New Search]